The October 2023 issue of the Journal of Drugs in Dermatology (JDD) focuses on atopic dermatitis and features mix of original articles, letters to the editor, and case reports. Among many of the topics explored in this issue are statins for treating actinic porokeratosis, ant venom-based ceramide therapy, the psychosocial burden of skin disease among skin of color consumers, treatment of lichen pl … Continue reading "JDD October 2023 Issue Highlights | Special Topic: Atopic Dermatitis"
Laser-assisted drug delivery (LAD) is a new method of locally delivering treatments for some skin disorders. Dr. Jill Waibel, Subsection Chief of Dermatology at Baptist Hospital of Miami, shared pearls in the emerging technique at the inaugural Pigmentary Disorders Exchange Symposium. Continue reading this article for more information on this novel therapy.
The basics of laser-assisted delivery … Continue reading "Laser-Assisted Drug Delivery | Practical Pearls from the Expert"
Alopecia areata is a CD8+ T-lymphocyte driven autoimmune disorder leading to reversible hair loss. While most commonly presenting as isolated well-demarcated non-cicatricial alopecic patches on the scalp, subtypes of alopecia areata include alopecia totalis with loss of all scalp hair and alopecia universalis with complete loss of all body hair. Although primarily an idiopathic condition, several … Continue reading "Rituximab-Induced Alopecia Universalis in a Patient With Bullous Pemphigoid"
If you find diagnosing disorders of hyperpigmentation challenging, then this is just for you! I had the privilege of attending the 2023 ODAC Dermatology, Aesthetic, and Surgical Conference to learn about disorders of hyperpigmentation from Dr. Nada Elbuluk. Dr. Elbuluk is an Associate Professor and Director of the Skin of Color Program and Pigmentary Disorders Clinic at the University of Southern … Continue reading "Practical Pearls for Diagnosing Disorders of Hyperpigmentation"
